Age-dependent decline in β-cell function assessed by an oral glucose tolerance test-based disposition index

Journal of Diabetes Investigation

Volumn 2, Issue 4, 2011, Pages 293-296

  Komada, Hisako ^a   Sakaguchi, Kazuhiko ^a   Takeda, Kazuo ^b   Hirota, Yushi ^b   Hashimoto, Naoko ^b   Okuno, Yoko ^a   Ogawa, Susumu Seino ^a   Ogawa, Wataru ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO INDUSTRIAL HEALTH ASSOCIATION   (Japan)

Author keywords

Cell function; Aging; Oral glucose tolerance test

Indexed keywords

GLUCOSE;

ADULT; AGING; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; YOUNG ADULT;

EID: 84885380702     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2010.00099.x     Document Type: Article

References (15)

1. Scheen AJ. Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? Diabetes Metab 2005; 2: 5S27-5S34.
2. Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab 2003; 284: E7-E12.
3. Bergman RN, Finegood DT, Kahn SE. The evolution of b-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002; 32(suppl 3): 35-45.
4. Roder ME, Schwartz RS, Prigeon RL, et al. Reduced pancreatic b cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels. J Clin Endocrinol Metab 2000; 85: 2275-2280.
5. Basu R, Breda E, Oberg AL, et al. Mechanisms of the ageassociated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 2003; 52: 1738-1748.
6. Chang AM, Smith MJ, Galecki AT, et al. Impaired b-cell function in human aging: response to nicotinic acidinduced insulin resistance. J Clin Endocrinol Metab 2006; 91: 3303-3309.
7. Utzschneider KM, Tong J, Montgomery B, et al. The dipeptidyl peptidase-4 inhibitor vildagliptin improves b-cell function and insulin sensitivity in subjects with impaired fasting glucose. Diabetes Care 2008; 31: 108-113.
8. Retnakaran R, Shen S, Hanley AJ, et al. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity 2008; 16: 1901- 1907.
9. Utzschneider KM, Prigeon RL, Faulenbach MV, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32: 335-341.
10. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462- 1470.
11. DeFronzo RA. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 1979; 4: 493-501.
12. DeFronzo RA. Glucose intolerance and aging. Diabetes Care 1981; 4: 493-501.
13. Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science 2005; 307: 380-384.
14. McNeely MJ, Boyko EJ. Type 2 diabetes prevalence in Asian Americans: results of a national health survey. Diabetes Care 2004; 27: 66-69.
15. Shai I, Jiang R, Manson JE, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care 2006; 29: 1585-1590.